Badri N Vardarajan1, Kelley M Faber2, Thomas D Bird3, David A Bennett4, Roger Rosenberg5, Bradley F Boeve6, Neill R Graff-Radford7, Alison M Goate8, Martin Farlow9, Robert A Sweet10, Rafael Lantigua11, Martin Z Medrano12, Ruth Ottman13, Daniel J Schaid14, Tatiana M Foroud2, Richard Mayeux15. 1. Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York2Gertrude H. Sergievsky Center, Columbia University College of Physicians and Surgeons, New York, New York. 2. Department of Medical and Molecular Genetics, Indiana University, Indianapolis. 3. Department of Neurology, University of Washington, Seattle5Department of Medicine, University of Washington, Seattle. 4. Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois. 5. Department of Neurology and Neurotherapeutics, The University of Texas Southwestern Medical Center, Dallas. 6. Department of Neurology, Mayo Clinic, Rochester, Minnesota. 7. Department of Neurology, Mayo Clinic, Jacksonville, Florida. 8. Department of Psychiatry and Genetics, Knight Alzheimer's Disease Research Center, Washington University, St Louis, Missouri11Hope Center for Neurological Disorders, Washington University, St Louis, Missouri. 9. Department of Neurology, Indiana University Center for Alzheimer's Disease and Related Disorders, Indianapolis. 10. Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania14Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania15Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania. 11. Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York16Department of Medicine, Columbia University, New York, New York. 12. Universidad Tecnológica de Santiago, Santiago, Dominican Republic18currently with Department of Geriatrics, Pontificia Universidad Católica Madre y Maestra, Santiago, Dominican Republic. 13. Gertrude H. Sergievsky Center, Columbia University College of Physicians and Surgeons, New York, New York3Department of Medical and Molecular Genetics, Indiana University, Indianapolis19Department of Epidemiology, Columbia University, New York, New York20. 14. Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. 15. Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York2Gertrude H. Sergievsky Center, Columbia University College of Physicians and Surgeons, New York, New York22Department of Neurolo.
Abstract
IMPORTANCE: Late-onset Alzheimer disease (LOAD), defined as onset of symptoms after age 65 years, is the most common form of dementia. Few reports investigate incidence rates in large family-based studies in which the participants were selected for family history of LOAD. OBJECTIVE: To determine the incidence rates of dementia and LOAD in unaffected members in the National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA) family studies. DESIGN, SETTING, AND PARTICIPANTS: Families with 2 or more affected siblings who had a clinical or pathological diagnosis of LOAD were recruited as a part of the NIA-LOAD/NCRAD Family Study. A cohort of Caribbean Hispanics with familial LOAD was recruited in a different study at the Taub Institute for Research on Alzheimer's Disease and the Aging Brain in New York and from clinics in the Dominican Republic as part of the EFIGA study. MAIN OUTCOMES AND MEASURES: Age-specific incidence rates of LOAD were estimated in the unaffected family members in the NIA-LOAD/NCRAD and EFIGA data sets. We restricted analyses to families with follow-up and complete phenotype information, including 396 NIA-LOAD/NCRAD and 242 EFIGA families. Among the 943 at-risk family members in the NIA-LOAD/NCRAD families, 126 (13.4%) developed dementia, of whom 109 (86.5%) met criteria for LOAD. Among 683 at-risk family members in the EFIGA families, 174 (25.5%) developed dementia during the study period, of whom 145 (83.3%) had LOAD. RESULTS: The annual incidence rates of dementia and LOAD in the NIA-LOAD/NCRAD families per person-year were 0.03 and 0.03, respectively, in participants aged 65 to 74 years; 0.07 and 0.06, respectively, in those aged 75 to 84 years; and 0.08 and 0.07, respectively, in those 85 years or older. Incidence rates in the EFIGA families were slightly higher, at 0.03 and 0.02, 0.06 and 0.05, 0.10 and 0.08, and 0.10 and 0.07, respectively, in the same age groups. Contrasting these results with the population-based estimates, the incidence was increased by 3-fold for NIA-LOAD/NCRAD families (standardized incidence ratio, 3.44) and 2-fold among the EFIGA compared with the NIA-LOAD/NCRAD families (1.71). CONCLUSIONS AND RELEVANCE: The incidence rates for familial dementia and LOAD in the NIA-LOAD/NCRAD and EFIGA families are significantly higher than population-based estimates. The incidence rates in all groups increase with age. The higher incidence of LOAD can be explained by segregation of Alzheimer disease-related genes in these families or shared environmental risks.
IMPORTANCE: Late-onset Alzheimer disease (LOAD), defined as onset of symptoms after age 65 years, is the most common form of dementia. Few reports investigate incidence rates in large family-based studies in which the participants were selected for family history of LOAD. OBJECTIVE: To determine the incidence rates of dementia and LOAD in unaffected members in the National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA) family studies. DESIGN, SETTING, AND PARTICIPANTS: Families with 2 or more affected siblings who had a clinical or pathological diagnosis of LOAD were recruited as a part of the NIA-LOAD/NCRAD Family Study. A cohort of Caribbean Hispanics with familial LOAD was recruited in a different study at the Taub Institute for Research on Alzheimer's Disease and the Aging Brain in New York and from clinics in the Dominican Republic as part of the EFIGA study. MAIN OUTCOMES AND MEASURES: Age-specific incidence rates of LOAD were estimated in the unaffected family members in the NIA-LOAD/NCRAD and EFIGA data sets. We restricted analyses to families with follow-up and complete phenotype information, including 396 NIA-LOAD/NCRAD and 242 EFIGA families. Among the 943 at-risk family members in the NIA-LOAD/NCRAD families, 126 (13.4%) developed dementia, of whom 109 (86.5%) met criteria for LOAD. Among 683 at-risk family members in the EFIGA families, 174 (25.5%) developed dementia during the study period, of whom 145 (83.3%) had LOAD. RESULTS: The annual incidence rates of dementia and LOAD in the NIA-LOAD/NCRAD families per person-year were 0.03 and 0.03, respectively, in participants aged 65 to 74 years; 0.07 and 0.06, respectively, in those aged 75 to 84 years; and 0.08 and 0.07, respectively, in those 85 years or older. Incidence rates in the EFIGA families were slightly higher, at 0.03 and 0.02, 0.06 and 0.05, 0.10 and 0.08, and 0.10 and 0.07, respectively, in the same age groups. Contrasting these results with the population-based estimates, the incidence was increased by 3-fold for NIA-LOAD/NCRAD families (standardized incidence ratio, 3.44) and 2-fold among the EFIGA compared with the NIA-LOAD/NCRAD families (1.71). CONCLUSIONS AND RELEVANCE: The incidence rates for familial dementia and LOAD in the NIA-LOAD/NCRAD and EFIGA families are significantly higher than population-based estimates. The incidence rates in all groups increase with age. The higher incidence of LOAD can be explained by segregation of Alzheimer disease-related genes in these families or shared environmental risks.
Authors: Katarzyna Bryc; Christopher Velez; Tatiana Karafet; Andres Moreno-Estrada; Andy Reynolds; Adam Auton; Michael Hammer; Carlos D Bustamante; Harry Ostrer Journal: Proc Natl Acad Sci U S A Date: 2010-05-05 Impact factor: 11.205
Authors: L Letenneur; V Gilleron; D Commenges; C Helmer; J M Orgogozo; J F Dartigues Journal: J Neurol Neurosurg Psychiatry Date: 1999-02 Impact factor: 10.154
Authors: J M Manubens; J M Martínez-Lage; F Lacruz; J Muruzabal; R Larumbe; C Guarch; T Urrutia; P Sarrasqueta; P Martínez-Lage; W A Rocca Journal: Neuroepidemiology Date: 1995 Impact factor: 3.282
Authors: H C Liu; P Chou; K N Lin; S J Wang; J L Fuh; H C Lin; C Y Liu; G S Wu; E B Larson; L R White Journal: Psychol Med Date: 1994-08 Impact factor: 7.723
Authors: O Hagnell; A Franck; A Gräsbeck; R Ohman; L Ojesjö; L Otterbeck; B Rorsman Journal: Eur Arch Psychiatry Clin Neurosci Date: 1991 Impact factor: 5.270
Authors: T Yoshitake; Y Kiyohara; I Kato; T Ohmura; H Iwamoto; K Nakayama; S Ohmori; K Nomiyama; H Kawano; K Ueda Journal: Neurology Date: 1995-06 Impact factor: 9.910
Authors: Sandra Barral; Badri N Vardarajan; Dolly Reyes-Dumeyer; Kelley M Faber; Thomas D Bird; Debby Tsuang; David A Bennett; Roger Rosenberg; Bradley F Boeve; Neill R Graff-Radford; Alison M Goate; Martin Farlow; Rafael Lantigua; Martin Z Medrano; Xinbing Wang; M Ilyas Kamboh; Mahmud Muhiedine Barmada; Daniel J Schaid; Tatiana M Foroud; Elise A Weamer; Ruth Ottman; Robert A Sweet; Richard Mayeux Journal: Neurobiol Aging Date: 2015-08-15 Impact factor: 4.673
Authors: Angel Piriz; Dolly Reyes; Atul Narkhede; Vanessa A Guzman; Fawad Viqar; Irene B Meier; Mariana Budge; Pedro Mena; Stephen Dashnaw; Joseph Lee; Christiane Reitz; Jose Gutierrez; Luis Campos; Martin Medrano; Rafael Lantigua; Richard Mayeux; Adam M Brickman Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Badri N Vardarajan; Dolly Reyes-Dumeyer; Angel L Piriz; Rafael A Lantigua; Martin Medrano; Diones Rivera; Ivonne Z Jiménez-Velázquez; Eden Martin; Margaret A Pericak-Vance; William Bush; Lindsay Farrer; Jonathan L Haines; Li-San Wang; Yuk Yee Leung; Gerard Schellenberg; Walter Kukull; Philip De Jager; David A Bennett; Julie A Schneider; Richard Mayeux Journal: Alzheimers Dement Date: 2022-02-09 Impact factor: 16.655
Authors: Soraya Herrera-Espejo; Borja Santos-Zorrozua; Paula Alvarez-Gonzalez; Idoia Martin-Guerrero; Marian M de Pancorbo; Africa Garcia-Orad; Elixabet Lopez-Lopez Journal: Mol Neurobiol Date: 2020-09-06 Impact factor: 5.590
Authors: Giuseppe Tosto; Thomas D Bird; David A Bennett; Bradley F Boeve; Adam M Brickman; Carlos Cruchaga; Kelley Faber; Tatiana M Foroud; Martin Farlow; Alison M Goate; Neill R Graff-Radford; Rafael Lantigua; Jennifer Manly; Ruth Ottman; Roger Rosenberg; Daniel J Schaid; Nicole Schupf; Yaakov Stern; Robert A Sweet; Richard Mayeux Journal: JAMA Neurol Date: 2016-10-01 Impact factor: 18.302